Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home Themes AI

Samsung Q1 Profit to Drop 21% Amid Weak AI Chip Sales and Foundry Losses

by Team Lumida
April 7, 2025
in AI
Reading Time: 4 mins read
A A
0
Samsung signage

Photo by Kote Puerto on Unsplash

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

Powered by lumidawealth.com

  • Samsung Electronics is expected to report a 21% decline in Q1 operating profit to 5.2 trillion won ($3.62 billion), down from 6.6 trillion won a year ago.
  • Weak AI chip sales and continued losses in its contract chip manufacturing (foundry) business are the primary drivers of the decline.
  • Falling DRAM and NAND flash memory prices, coupled with U.S. tariffs on consumer electronics, are adding to Samsung’s challenges.
  • Samsung’s mobile and network business is expected to post a slight profit increase to 3.7 trillion won, supported by higher smartphone shipments and favorable currency effects.

What Happened?

Samsung Electronics is grappling with a challenging quarter as its Q1 operating profit is projected to fall 21% year-over-year. The company’s chip division, which has been underperforming since mid-2024, continues to struggle with weak demand for high-performance AI chips and declining DRAM and NAND flash memory prices.

Samsung’s reliance on less advanced memory chips for Chinese customers, who are facing U.S. export restrictions, has further hurt profitability. Meanwhile, its foundry business remains in the red, with the start-up of its new U.S. factory delayed to 2027 due to a lack of major production orders.

Adding to the pressure, U.S. tariffs on consumer electronics are expected to raise costs for Samsung’s products, including smartphones, TVs, and home appliances, potentially dampening consumer demand.


Why It Matters?

Samsung’s struggles highlight the challenges faced by global tech giants in navigating a volatile market shaped by geopolitical tensions, trade policies, and shifting consumer demand. The company’s underperformance in the AI chip market, where rival SK Hynix is thriving, underscores the importance of innovation and high-end product offerings in maintaining competitiveness.

The impact of U.S. tariffs on Samsung’s consumer electronics business further complicates its outlook, as higher costs could erode demand and profitability. Meanwhile, delays in its U.S. foundry operations signal ongoing challenges in diversifying its production base and securing major clients.


What’s Next?

Samsung is working on a redesigned version of its advanced HBM chips to regain competitiveness in the AI chip market. However, analysts expect the company’s profitability to remain under pressure in the near term due to volatile memory prices and geopolitical headwinds.

The company may also explore diversifying its production base as part of its long-term strategy to mitigate the impact of tariffs, though such efforts will take years to materialize. Investors will be closely watching Samsung’s Q1 earnings report on Tuesday for further insights into its recovery plans and market outlook.

Source
Previous Post

Tether CEO Paolo Ardoino Discusses the Stablecoin Giant’s Profitable Business and Controversies

Next Post

Emerging Drugs from Lilly, Amgen, and Novartis Target Untreatable Cholesterol Linked to Heart Disease

Recommended For You

Sword Health Acquires Meditation App Headspace for $300M, Expanding AI Healthcare Platform Into Mental Health and Wellness

by Team Lumida
11 minutes ago
Sword Health Acquires Meditation App Headspace for $300M, Expanding AI Healthcare Platform Into Mental Health and Wellness

AI healthcare startup Sword Health buys popular meditation app Headspace for nearly $300M all-cash; acquisition aims to deliver AI-personalized mental health and cardiometabolic care.

Read more

OpenAI Eyes $1.2 Trillion Valuation in Private Funding Round Before 2027+ IPO, Capitalizing on GPT-5.6 Success

by Team Lumida
3 hours ago
OpenAI Eyes $1.2 Trillion Valuation in Private Funding Round Before 2027+ IPO, Capitalizing on GPT-5.6 Success

Sam Altman's ChatGPT maker is in early talks to raise fresh capital at 41% above March's $852 billion valuation, signaling confidence in new model momentum.

Read more

Apple’s 16-Product Roadmap Through Mid-2027 Spotlights Siri AI Overhaul and Biggest Push Into Smart Home

by Team Lumida
1 day ago
Apple’s 16-Product Roadmap Through Mid-2027 Spotlights Siri AI Overhaul and Biggest Push Into Smart Home

CEO John Ternus is executing Apple's most ambitious product cycle in history, with Siri AI at the center of HomePods, Macs, iPads, and iPhones launching through spring 2027.

Read more

Model ML Seeks $100 Million to Automate Investment Banking Grunt Work as Banks Accelerate AI Adoption

by Team Lumida
1 day ago
Model ML Seeks $100 Million to Automate Investment Banking Grunt Work as Banks Accelerate AI Adoption

The startup, valued above $1 billion, aims to expand AI agents automating due diligence, pitch decks, and research memos for JPMorgan, HSBC, and PwC.

Read more

Gates Foundation Pledges $1 Billion for AI Equity as Bill Gates Warns of Widening Rich-Poor Divide

by Team Lumida
1 day ago
Gates Foundation Pledges $1 Billion for AI Equity as Bill Gates Warns of Widening Rich-Poor Divide

The Gates Foundation will spend at least $1 billion over two years to ensure AI benefits the global poor, with focus on education, healthcare, and agriculture.

Read more

Samsung Leads $230 Million Bet on Euclyd, Dutch AI Chip Startup Challenging Nvidia’s Inference Dominance

by Team Lumida
1 day ago
Nvidia’s AI Demand Surge: Hon Hai Ramps Up Server Production

Samsung and European investors back Dutch chipmaker Euclyd to build specialized AI inference processors, signaling a broader push to break Nvidia's GPU monopoly.

Read more

Rumble Shares Jump as Report Reveals Anthropic as the $13.7 Billion Customer Behind Its August Cloud Deal

by Team Lumida
2 days ago
Rumble Shares Jump as Report Reveals Anthropic as the $13.7 Billion Customer Behind Its August Cloud Deal

The Information reported that Anthropic is the previously unnamed customer behind Rumble's $13.7 billion compute deal, giving the AI lab access to GPUs from the Georgia site of...

Read more

Kioxia Weighs $10 Billion US Listing to Follow SK Hynix’s Record $26.5 Billion ADR Offering

by Team Lumida
2 days ago
Kioxia Weighs $10 Billion US Listing to Follow SK Hynix’s Record $26.5 Billion ADR Offering

Japanese NAND maker Kioxia is in talks with Bank of America, Goldman Sachs and JPMorgan on a potential US ADR listing raising at least $10 billion as early...

Read more

Anthropic Tells Investors It Will Post a Second Straight Profitable Quarter Ahead of Nasdaq IPO

by Team Lumida
2 days ago
Anthropic Tells Investors It Will Post a Second Straight Profitable Quarter Ahead of Nasdaq IPO

Anthropic told a small group of shareholders its adjusted operating income will be positive for a second consecutive quarter, with gross margins above 80% ahead of a Nasdaq...

Read more

Eric Trump-Backed Foundation Lands $24 Million Pentagon Contract to Test Combat Humanoid Robots

by Team Lumida
2 days ago
Eric Trump-Backed Foundation Lands $24 Million Pentagon Contract to Test Combat Humanoid Robots

Foundation, which leases its Phantom MK-1 humanoid robot for $100,000 a year, has secured a $24 million Pentagon contract and deployed units with the Air Force and in...

Read more
Next Post
white and blue medication pill blister pack

Emerging Drugs from Lilly, Amgen, and Novartis Target Untreatable Cholesterol Linked to Heart Disease

Donald Trump beside man in black suit

Trump Demands Trade Deficit Resolution Before Any Deal With China Amid Global Market Turmoil

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

September Rate Cut Likely as Job Market Risks Increase, Says Fed

Looser Fed Capital Rules Could Hand Big Banks a Massive New Stimulus

March 17, 2026
India Lures Tech Giants: Microsoft and Amazon Bet Big on AI

India Lures Tech Giants: Microsoft and Amazon Bet Big on AI

June 18, 2024
a white and blue square with a blue logo on it

Ex-Meta Executive Alleges Company Undermined U.S. Security by Aiding China’s AI Development

April 9, 2025

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Opinions
    • Op-Ed
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Op-Ed
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto data centers Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Intel Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018